Sponsor or institution

Clinical trials and research at Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. that are recruiting, in China. By phase: Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
HW243040 first-in-human safety in healthy adults Phase 1 Changsha, Hunan Recruiting Jul 30, 2026
HW221043 in people with advanced solid tumors Phase 1 Shanghai, Shanghai Municipality Recruiting Jul 22, 2026
Single-dose safety and pharmacokinetics of HW241045 in healthy adults Phase 1 Beijing Recruiting Mar 4, 2026
HW211026 ointment for facial actinic keratosis Phase 1 Shanghai Recruiting Jan 6, 2026

All recruiting trials (4)

Quick answers

How many clinical trials run by Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.